Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Posner

Showing results (201-210 of 247) with videos related to

Pageof 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neckRoy B Tishler, Marshall R Posner, Charles M Norris, et al.
AIDS Research and Human Retroviruses|May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulinsA Li, T W Baba, J Sodroski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neckA D Colevas, C M Norris, R B Tishler, et al.
Anticancer Research|April 13, 2016
Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck CancerRajan P Dang, Valerie H LE, Brett A Miles, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 31, 2009
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patientsKathleen Settle, Marshall R Posner, Lisa M Schumaker, et al.
Cancer|August 24, 2005
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinomaPhilip C Amrein, John R Clark, Jeffrey G Supko, et al.
Oral Oncology|September 4, 2020
A new face of the HPV epidemic: Oropharyngeal cancer in the elderlyDaniel R Dickstein, Marc A Egerman, Anthony H Bui, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapyHale B Caglar, Roy B Tishler, Megan Othus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Oral Oncology|August 19, 2024
Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancerGlenn J Hanna, Jamie Jabalee, John N Lukens, et al.
Pageof 25

Showing results (201-210 of 247) with videos related to

Sort By:
Pageof 25
International Journal of Radiation Oncology, Biology, Physics|May 10, 2006
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neckRoy B Tishler, Marshall R Posner, Charles M Norris, et al.
AIDS Research and Human Retroviruses|May 20, 1997
Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulinsA Li, T W Baba, J Sodroski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neckA D Colevas, C M Norris, R B Tishler, et al.
Anticancer Research|April 13, 2016
Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck CancerRajan P Dang, Valerie H LE, Brett A Miles, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 31, 2009
Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patientsKathleen Settle, Marshall R Posner, Lisa M Schumaker, et al.
Cancer|August 24, 2005
Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinomaPhilip C Amrein, John R Clark, Jeffrey G Supko, et al.
Oral Oncology|September 4, 2020
A new face of the HPV epidemic: Oropharyngeal cancer in the elderlyDaniel R Dickstein, Marc A Egerman, Anthony H Bui, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapyHale B Caglar, Roy B Tishler, Megan Othus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2009
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neckL J Wirth, A M Allen, M R Posner, et al.
Oral Oncology|August 19, 2024
Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancerGlenn J Hanna, Jamie Jabalee, John N Lukens, et al.
Pageof 25